Bio-View Ltd (TLV:BIOV)
Israel
· Delayed Price · Currency is ILS · Price in ILA 29.00
+1.10 (3.94%)
Apr 1, 2025, 10:15 AM IDT
Bio-View Revenue
In the year 2024, Bio-View had annual revenue of 25.66M ILS, down -26.21%. Bio-View had revenue of 17.04M in the half year ending June 30, 2024, with 36.39% growth.
Revenue
25.66M
Revenue Growth
-26.21%
P/S Ratio
1.43
Revenue / Employee
777.42K
Employees
33
Market Cap
35.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | -9.11M | -26.21% |
| Dec 31, 2023 | 34.77M | 5.62M | 19.29% |
| Dec 31, 2022 | 29.15M | -1.37M | -4.48% |
| Dec 31, 2021 | 30.51M | 4.55M | 17.54% |
| Dec 31, 2020 | 25.96M | -9.83M | -27.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 60.26B |
| Danel (Adir Yeoshua) | 2.77B |
| Kamada | 586.24M |
| Bait Bakfar | 103.40M |
| Novolog (Pharm-Up 1966) | 2.02B |
| Ilex Medical | 982.96M |
| BrainsWay | 149.39M |
| SofWave Medical | 217.27M |